Single nucleus gene expression in moderate and compulsive opioid self-administration in a rodent model of HIV
HIV啮齿动物模型中度和强迫性阿片类药物自我给药的单核基因表达
基本信息
- 批准号:10682961
- 负责人:
- 金额:$ 134.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:AbstinenceAddressAdoptedAlzheimer&aposs DiseaseAnimal ModelAstrocytesAutomobile DrivingBehaviorBehavioral ParadigmBindingBrain regionCell NucleusCellsCentral Nervous SystemChronicClinicalComplementComputing MethodologiesConsultationsDSM-IVDataData Coordinating CenterDependenceDevelopmentDiseaseDisease ProgressionDissectionDrug AddictionDrug abuseDrug usageFentanylFreezingFundingGene ExpressionGeneral PopulationGenesGenomicsHIVHIV InfectionsHIV-1HeadHeroinHumanImpaired cognitionIndividualIntakeIntravenousLymphocyteMacrophageMalignant NeoplasmsMethamphetamineMethodsMicrogliaModelingMolecularMolecular AnalysisMolecular ProfilingMotivationNational Institute of Drug AbuseNegative ReinforcementsNerve DegenerationNeurogliaNeuronsNeuropathogenesisNeuropsychologyNeurosciencesOpioidOxycodonePathogenesisPathogenicityPatternPersonsPharmaceutical PreparationsProteinsRat TransgeneRattusRecording of previous eventsRecreationRegulator GenesResearch PersonnelResourcesRiskRodent ModelSamplingSelf AdministrationSourceSubstance Use DisorderSubstance abuse problemSynapsesSystems BiologyTestingTherapeuticTissuesTranscriptTransgenesTransgenic OrganismsViruscell typecomorbiditydesigndrug mechanismexperiencegene networkgene regulatory networkgenetic signaturegenome-widehuman modelimprovednegative emotional statenerve injuryneuroAIDSneuroinflammationnew therapeutic targetnon-compliancenovel therapeuticsopioid abuseopioid injectionopioid useopioid use disorderpreventprogramspublic health relevancepublic repositoryreconstructionsingle cell analysissingle nucleus RNA-sequencingsynergismtherapeutic targettherapeutically effectivetranscriptome sequencingtranscriptomicsvalidation studiesviral transmission
项目摘要
Summary
The abuse of opioid drugs is associated with treatment non-compliance, greater risk of viral transmission,
and more rapid clinical progression of HIV disease. The overarching hypothesis behind the present project is
that the analysis of molecular profiles of neuronal and glia cells at the single cell level in drug abuse-relevant
brain regions by single nucleus RNA-Seq (snRNA-Seq) will reveal key genes that are dysregulated by the
interaction of HIV with opioid abuse, resulting in neurodegeneration and cognitive impairment. To test the
present hypothesis, we propose to use validated systems biology strategies for the reconstruction and
interrogation of a genome-scale integrated gene regulatory network in conjunction with snRNA-Seq from HIV
transgenic (Tg) rats, which harbor a non-replicating HIV-1 transgene expressing chronic low-levels of multiple
HIV-1 proteins in disease-relevant cell types, and wild-type rats.
The occasional but limited use of a drug is clinically distinct from dependent drug use, which is
characterized by the emergence of dependence and a negative emotional state when access to the drug is
prevented that drives negative reinforcement, a powerful source of motivation for drug seeking. Therefore, we
will use a state-of-the-art paradigm of voluntary intravenous opioid self-administration under short access
(ShA) conditions, which is characterized by a non-dependent, “recreational” pattern of drug use, and long
access (LgA) conditions, which leads to dependent drug intake. Escalated drug intake under LgA conditions is
highly relevant to human substance use disorder (SUD) as it has been suggested that it models all 7 of the
criteria for drug addiction in the Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV and 7 of the 11
criteria in the DSM-V. We showed that HIV Tg rats self-administering oxycodone in this LgA paradigm of
escalated self-administration display increased neural injury and cognitive impairment.
The project will address the following vexing question about opioid abuse in the setting of HIV infection:
what are the cell types and cell states that drive neuroinflammation, neurodegeneration, virus expression, and
escalated (dependent) opioid self-administration and cognitive impairment in the setting of HIV?
Overall, this collaborative interdisciplinary proposal integrating single cell level transcriptomics, state-of-the-
art behavior methods in HIV Tg and wild-type rats, and computational strategies for the deconvolution of the
gene regulatory network at the single cell level will elucidate key mechanisms that underlie the effects of HIV
and opioid abuse and their detrimental interactions on neuroHIV progression, virus expression and
persistence. The results will indicate transformative new mechanistic hypotheses that may lead to novel
therapeutic concepts for opioid use disorder (OUD) in the setting of HIV and will establish key resources for the
neuroHIV field to be made publicly available through the SCORCH data coordination center and other public
repositories.
摘要
阿片类药物的滥用与治疗不依从、更大的病毒传播风险、
并且HIV疾病的临床进展更快。本项目背后的首要假设是
与药物滥用相关的单细胞水平的神经细胞和神经胶质细胞的分子图谱分析
单核RNA-Seq(SnRNA-Seq)的大脑区域将揭示受
艾滋病毒与阿片类药物滥用的相互作用,导致神经退化和认知障碍。要测试
目前的假设,我们建议使用经过验证的系统生物学策略来重建和
结合人类免疫缺陷病毒SnRNA-Seq的基因组级整合基因调控网络的构建
转基因(TG)大鼠,携带非复制型HIV-1转基因表达慢性低水平的
疾病相关细胞类型中的HIV-1蛋白,以及野生型老鼠。
偶尔但有限的药物使用在临床上不同于依赖药物的使用,后者是
以出现依赖和当获得药物时的负面情绪状态为特征的
防止这种情况会导致负面强化,这是寻求毒品的强大动力来源。因此,我们
将在短时间内使用最先进的自愿静脉注射阿片类药物自我给药范例
(Sa)以非依赖、“娱乐”的吸毒模式为特征的条件,以及长期
进入(LGA)条件,导致依赖药物摄取。在LGA条件下增加的药物摄入量是
与人类物质使用障碍(SUD)高度相关,因为有人建议它模拟所有7个
《精神疾病诊断和统计手册》(DSM)中的药物成瘾标准--第四部分和第七部分
DSM-V中的标准我们发现HIV TG大鼠在这种LGA范式中自我给药羟考酮
自我管理升级会增加神经损伤和认知障碍。
该项目将解决关于在艾滋病毒感染环境中滥用阿片类药物的下列令人烦恼的问题:
导致神经炎症、神经退行性变、病毒表达和
艾滋病毒环境中阿片类药物自我管理和认知障碍的升级?
总体而言,这一跨学科的协作性提案整合了单细胞水平的转录组学、最新进展-
在HIV TG和野生型大鼠中的ART行为方法以及去卷积的计算策略
单细胞水平的基因调控网络将阐明艾滋病毒影响的关键机制
和阿片类药物滥用及其对神经艾滋病毒进展、病毒表达和
坚持不懈。结果将表明变革性的新的机械论假说可能导致新的
艾滋病毒背景下阿片使用障碍(OUD)的治疗概念,并将为
将通过SCARCH数据协调中心和其他公共机构公开提供神经艾滋病毒领域
储存库。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PIETRO P SANNA其他文献
PIETRO P SANNA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PIETRO P SANNA', 18)}}的其他基金
Transcriptional adaptations driving the intensification of alcohol-seeking in dependent rats undergoing prolonged abstinence
转录适应导致长期戒酒的依赖性大鼠对酒精的渴求加剧
- 批准号:
10540014 - 财政年份:2022
- 资助金额:
$ 134.86万 - 项目类别:
Single nucleus gene expression in moderate and compulsive drug self-administration in a rodent model of HIV
HIV啮齿动物模型中度和强迫性自我给药的单核基因表达
- 批准号:
10592330 - 财政年份:2022
- 资助金额:
$ 134.86万 - 项目类别:
Single nucleus gene expression in moderate and compulsive drug self-administration in a rodent model of HIV
HIV啮齿动物模型中度和强迫性自我给药的单核基因表达
- 批准号:
10454706 - 财政年份:2022
- 资助金额:
$ 134.86万 - 项目类别:
Transcriptional adaptations driving the intensification of alcohol-seeking in dependent rats undergoing prolonged abstinence
转录适应导致长期戒酒的依赖性大鼠对酒精的渴求加剧
- 批准号:
10686229 - 财政年份:2022
- 资助金额:
$ 134.86万 - 项目类别:
An Innovative Approach to Identify Correctors of Metabolic Complications in HIV
一种识别 HIV 代谢并发症校正因子的创新方法
- 批准号:
10395011 - 财政年份:2021
- 资助金额:
$ 134.86万 - 项目类别:
Systems biology of RNA Modifications in HIV/AIDS and Substance Use Disorders
HIV/艾滋病和药物滥用疾病中 RNA 修饰的系统生物学
- 批准号:
10318620 - 财政年份:2018
- 资助金额:
$ 134.86万 - 项目类别:
Identification of small molecules for neurological complications of HIV and substance abuse comorbidity
鉴定治疗 HIV 神经并发症和药物滥用合并症的小分子
- 批准号:
10343707 - 财政年份:2018
- 资助金额:
$ 134.86万 - 项目类别:
Epigenetic regulation of alcohol tolerance and dependence by methyl CpG binding protein 2
甲基 CpG 结合蛋白 2 对酒精耐受性和依赖性的表观遗传调控
- 批准号:
9133075 - 财政年份:2017
- 资助金额:
$ 134.86万 - 项目类别:
Neural substrates of opiate-HIV interactions.
阿片类药物与艾滋病毒相互作用的神经基质。
- 批准号:
9344568 - 财政年份:2016
- 资助金额:
$ 134.86万 - 项目类别:
Cocaine abuse and plasticity in the lateral hypothalamus
可卡因滥用和外侧下丘脑的可塑性
- 批准号:
8989877 - 财政年份:2015
- 资助金额:
$ 134.86万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 134.86万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 134.86万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 134.86万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 134.86万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 134.86万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 134.86万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 134.86万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 134.86万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 134.86万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 134.86万 - 项目类别:
Research Grant














{{item.name}}会员




